These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4052725)

  • 1. The effects of metoprolol and dazmegrel, alone and in combination, on arrhythmias induced by coronary artery occlusion in conscious rats.
    Leprán I; Parratt JR; Szekeres L; Wainwright CL
    Br J Pharmacol; 1985 Sep; 86(1):229-34. PubMed ID: 4052725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a combination of metoprolol and dazmegrel on myocardial infarct size in rats.
    Bullock GR; Leprán I; Parratt JR; Szekeres L; Wainwright CL
    Br J Pharmacol; 1985 Sep; 86(1):235-40. PubMed ID: 4052726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of beta-adrenoceptor blockade and of thromboxane synthetase inhibition, alone and in combination, on arrhythmias resulting from myocardial ischemia.
    Wainwright CL; Parratt JR
    Adv Myocardiol; 1985; 6():573-84. PubMed ID: 4039460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships between the severity of myocardial ischaemia, reperfusion-induced ventricular fibrillation, and the late administration of dazmegrel or nifedipine.
    Coker SJ; Parratt JR
    J Cardiovasc Pharmacol; 1985; 7(2):327-34. PubMed ID: 2581088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of dazoxiben on arrhythmias and ventricular fibrillation induced by coronary artery occlusion and reperfusion in anaesthetised greyhounds.
    Coker SJ; Parratt JR
    Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):87S-95S. PubMed ID: 6681710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metoprolol reduces reperfusion-induced fibrillation in the isolated rat heart: protection is secondary to bradycardia.
    Tosaki A; Szekeres L; Hearse DJ
    J Cardiovasc Pharmacol; 1987 Nov; 10(5):489-97. PubMed ID: 2447396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of CV4151, a thromboxane A2 synthetase inhibitor, on ventricular arrhythmias induced by coronary artery occlusion in rats.
    Umetani K; Tamura K; Komori S; Watanabe A; Ishihara T; Mochizuki S; Li B; Ijiri H
    Jpn Circ J; 1996 Jun; 60(6):349-54. PubMed ID: 8844301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiarrhythmic effects of selective beta 1- and beta 2- and nonselective beta-adrenoceptor blockade in normokalaemic and dietary-induced hypokalaemic rats.
    Winslow E; Walker G; Mason R
    J Cardiovasc Pharmacol; 1989 Nov; 14(5):673-80. PubMed ID: 2481179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of ventricular fibrillation by metoprolol in a pig model of acute myocardial ischaemia: absence of a major arrhythmogenic role for cyclic AMP.
    Muller CA; Opie LH; Hamm CW; Peisach M; Gihwala D
    J Mol Cell Cardiol; 1986 Apr; 18(4):375-87. PubMed ID: 3012099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure of cyclo-oxygenase inhibition to protect against arrhythmias induced by ischaemia and reperfusion: implications for the role of prostaglandins as endogenous myocardial protective substances.
    Wainwright CL; Parratt JR
    Cardiovasc Res; 1991 Feb; 25(2):93-100. PubMed ID: 1742769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effects of dazmegrel on the PAF potential of ouabain-induced cardiac arrhythmias.
    Salinas P; Barrigón S
    Eur J Pharmacol; 1991 Dec; 209(1-2):105-7. PubMed ID: 1814756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential antiarrhythmic effects of exogenous and endogenous bradykinin in the ischaemic rat heart in vivo.
    Sun W; Wainwright CL
    Coron Artery Dis; 1994 Jun; 5(6):541-50. PubMed ID: 7952414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastric mucosal protection with selective inhibition of thromboxane synthesis.
    Walt RP; Kemp RT; Filipowicz B; Davies JG; Bhaskar NK; Hawkey CJ
    Gut; 1987 May; 28(5):541-4. PubMed ID: 3474195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergism between UK 38485 and ICI 185282 against digoxin-induced arrhythmias in guinea-pigs.
    Kanzik I; Zengil H; Ipek N; Cakici I; Abacioglu N; Dörtlemez H
    Arch Int Pharmacodyn Ther; 1991; 312():55-65. PubMed ID: 1772341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further evidence that thromboxane exacerbates arrhythmias: effects of UK38485 during coronary artery occlusion and reperfusion in anaesthetized greyhounds.
    Coker SJ
    J Mol Cell Cardiol; 1984 Jul; 16(7):633-41. PubMed ID: 6433026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of the thromboxane synthetase inhibitor HOE 944, prostacyclin and indomethacin on reperfusion arrhythmias, cardiodynamics and metabolism in isolated ischemic rat hearts.
    Linz W; Lau HH; Beck G; Schökens BA
    Biomed Biochim Acta; 1988; 47(10-11):S23-6. PubMed ID: 3073762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of thromboxane synthetase inhibition on vulnerability to ventricular arrhythmia following coronary occlusion.
    O'Connor KM; Friehling TD; Kelliher GJ; MacNab MW; Wetstein L; Kowey PR
    Am Heart J; 1986 Apr; 111(4):683-8. PubMed ID: 3953390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photochemically induced thrombosis of the rat coronary artery and functional evaluation of thrombus formation by occurrence of ventricular arrhythmias. Effects of acetylsalicylic acid and a thromboxane A2 synthetase inhibitor of thrombus formation.
    Fukuchi M; Uematsu T; Araki S; Nakashima M
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Nov; 346(5):550-4. PubMed ID: 1470226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of beta-adrenoceptor blocking agents, with differing ancillary properties, on the arrhythmias resulting from acute coronary artery ligation in anaesthetized rats.
    Campbell CA; Parratt JR
    Br J Pharmacol; 1983 Aug; 79(4):939-46. PubMed ID: 6140049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the new class I antiarrhythmic agent Ro 22-9194, (2R)-2-amino-N-(2,6-dimethylphenyl)-N-[3-(3-pyridyl)propyl]propionamide D-tartrate, on ischemia- and reperfusion-induced arrhythmias in dogs: involvement of thromboxane A2 synthase inhibitory activity.
    Murakami M; Kinukawa M; Kanazawa T; Maruyama K; Miyagi M; Miyata H; Ujiie A
    J Pharmacol Exp Ther; 1996 Nov; 279(2):877-83. PubMed ID: 8930195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.